$KSS
KOHLS Corp Stock $kss

$kss Overview Financials Valuation SEC Filings Company Website

2017 Q2 Form 10-Q Financial Statement

#000088563917000015 Filed on June 02, 2017

Income Statement

Concept	2017 Q2	2016 Q2
Revenue	$4.065B	$3.972B
YoY Change	2.34%	-3.66%
Cost Of Revenue	$2.428B	$2.560B
YoY Change	-5.16%	-1.54%
Gross Profit	$1.398B	$1.412B
YoY Change	-0.99%	-7.29%
Gross Profit Margin	34.39%	35.55%
Selling, General & Admin	$1.214B	$1.008B
YoY Change	20.44%	-0.79%
% of Gross Profit	86.84%	71.39%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$238.0M	$234.0M
YoY Change	1.71%	3.08%
% of Gross Profit	17.02%	16.57%
Operating Expenses	$1.214B	$1.008B
YoY Change	20.44%	-0.79%
Operating Profit	$185.0M	$106.0M
YoY Change	74.53%	-62.14%
Interest Expense	-$76.00M	-$79.00M
YoY Change	-3.8%	-5.95%
% of Operating Profit	-41.08%	-74.53%
Other Income/Expense, Net
YoY Change
Pretax Income	$109.0M	$27.00M
YoY Change	303.7%	-86.22%
Income Tax	$43.00M	$10.00M
% Of Pretax Income	39.45%	37.04%
Net Earnings	$66.00M	$17.00M
YoY Change	288.24%	-86.61%
Net Earnings / Revenue	1.62%	0.43%
Basic Earnings Per Share	$0.39	$0.09
Diluted Earnings Per Share	$0.39	$0.09
COMMON SHARES
Basic Shares Outstanding	170.0M	183.0M
Diluted Shares Outstanding	171.0M	184.0M

Balance Sheet

Concept	2017 Q2	2016 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$625.0M	$423.0M
YoY Change	47.75%	-64.6%
Cash & Equivalents	$625.0M	$423.0M
Short-Term Investments
Other Short-Term Assets	$328.0M	$348.0M
YoY Change	-5.75%	2.96%
Inventory	$3.991B	$4.084B
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$4.944B	$4.855B
YoY Change	1.83%	-14.79%
LONG-TERM ASSETS
Property, Plant & Equipment	$8.069B	$8.230B
YoY Change	-1.96%	-3.38%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$231.0M	$219.0M
YoY Change	5.48%	-7.59%
Total Long-Term Assets	$8.300B	$8.449B
YoY Change	-1.76%	-3.5%
TOTAL ASSETS
Total Short-Term Assets	$4.944B	$4.855B
Total Long-Term Assets	$8.300B	$8.449B
Total Assets	$13.24B	$13.30B
YoY Change	-0.45%	-7.95%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.480B	$1.346B
YoY Change	9.96%	-18.18%
Accrued Expenses	$1.088B	$1.126B
YoY Change	-3.37%	-1.23%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$134.0M	$127.0M
YoY Change	5.51%	12.39%
Total Short-Term Liabilities	$2.839B	$2.647B
YoY Change	7.25%	-11.32%
LONG-TERM LIABILITIES
Long-Term Debt	$2.795B	$2.793B
YoY Change	0.07%	0.47%
Other Long-Term Liabilities	$674.0M	$558.0M
YoY Change	20.79%	0.36%
Total Long-Term Liabilities	$674.0M	$558.0M
YoY Change	20.79%	0.36%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.839B	$2.647B
Total Long-Term Liabilities	$674.0M	$558.0M
Total Liabilities	$3.513B	$3.205B
YoY Change	9.61%	-9.49%
SHAREHOLDERS EQUITY
Retained Earnings	$12.49B	$12.25B
YoY Change	1.95%	1.74%
Common Stock	$3.017B	$2.965B
YoY Change	1.75%	2.21%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$10.50B	$9.906B
YoY Change	6.03%	11.19%
Treasury Stock Shares
Shareholders Equity	$4.994B	$5.297B
YoY Change
Total Liabilities & Shareholders Equity	$13.24B	$13.30B
YoY Change	-0.45%	-7.95%

Cashflow Statement

Concept	2017 Q2	2016 Q2
OPERATING ACTIVITIES
Net Income	$66.00M	$17.00M
YoY Change	288.24%	-86.61%
Depreciation, Depletion And Amortization	$238.0M	$234.0M
YoY Change	1.71%	3.08%
Cash From Operating Activities	$46.00M	$140.0M
YoY Change	-67.14%	37.25%
INVESTING ACTIVITIES
Capital Expenditures	-$216.0M	-$177.0M
YoY Change	22.03%	0.57%
Acquisitions
YoY Change
Other Investing Activities	-$13.00M	-$3.000M
YoY Change	333.33%	200.0%
Cash From Investing Activities	-$203.0M	-$174.0M
YoY Change	16.67%	-0.57%
FINANCING ACTIVITIES
Cash Dividend Paid	$94.00M	$91.00M
YoY Change	3.3%	1.11%
Common Stock Issuance & Retirement, Net	$156.0M	$126.0M
YoY Change	23.81%	-14.29%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-292.0M	-$250.0M
YoY Change	16.8%	79.86%
NET CHANGE
Cash From Operating Activities	46.00M	$140.0M
Cash From Investing Activities	-203.0M	-$174.0M
Cash From Financing Activities	-292.0M	-$250.0M
Net Change In Cash	-449.0M	-$284.0M
YoY Change	58.1%	33.96%
FREE CASH FLOW
Cash From Operating Activities	$46.00M	$140.0M
Capital Expenditures	-$216.0M	-$177.0M
Free Cash Flow	$262.0M	$317.0M
YoY Change	-17.35%	14.03%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2017Q2	dei	Amendment Flag AmendmentFlag	false
CY2017Q2	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--02-03
CY2017Q2	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2017Q2	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2017
CY2017Q2	dei	Document Period End Date DocumentPeriodEndDate	2017-04-29
CY2017Q2	dei	Document Type DocumentType	10-Q
CY2017Q2	dei	Entity Central Index Key EntityCentralIndexKey	0000885639
CY2017Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	170481383	shares
CY2017Q2	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2017Q2	dei	Entity Registrant Name EntityRegistrantName	KOHLS CORP
CY2017Q2	dei	Trading Symbol TradingSymbol	KSS
CY2017Q2	kss	Forfeitedperformancerestrictedshareunits Forfeitedperformancerestrictedshareunits	0	shares
CY2017Q2	kss	Grantedperformancerestrictedshareunits Grantedperformancerestrictedshareunits	309000	shares
CY2016Q2	kss	Impairmentsstoreclosingandothercosts Impairmentsstoreclosingandothercosts	64000000	USD
CY2017Q2	kss	Impairmentsstoreclosingandothercosts Impairmentsstoreclosingandothercosts	0	USD
CY2016Q2	kss	Impairmentsstoreclosingandothercostscashflow Impairmentsstoreclosingandothercostscashflow	64000000	USD
CY2017Q2	kss	Impairmentsstoreclosingandothercostscashflow Impairmentsstoreclosingandothercostscashflow	0	USD
CY2016Q1	kss	Performance Restricted Shares Fair Value Beginning PerformanceRestrictedSharesFairValueBeginning	57.82
CY2017Q2	kss	Performance Restricted Shares Fair Value Ending PerformanceRestrictedSharesFairValueEnding	50.35
CY2017Q2	kss	Performance Restricted Shares Fair Value Forfeited PerformanceRestrictedSharesFairValueForfeited	0.00
CY2017Q2	kss	Performance Restricted Shares Fair Value Granted PerformanceRestrictedSharesFairValueGranted	40.42
CY2016Q1	kss	Performancerestrictedsharesunitsbeginning Performancerestrictedsharesunitsbeginning	512000	shares
CY2017Q2	kss	Performancerestrictedsharesunitsending Performancerestrictedsharesunitsending	716000	shares
CY2016Q2	kss	Property And Equipment Acquired Through Capital Lease And Financing Obligations PropertyAndEquipmentAcquiredThroughCapitalLeaseAndFinancingObligations	9000000	USD
CY2017Q2	kss	Property And Equipment Acquired Through Capital Lease And Financing Obligations PropertyAndEquipmentAcquiredThroughCapitalLeaseAndFinancingObligations	13000000	USD
CY2016Q2	kss	Sale Leaseback Other Payments Received SaleLeasebackOtherPaymentsReceived	4000000	USD
CY2017Q2	kss	Sale Leaseback Other Payments Received SaleLeasebackOtherPaymentsReceived	0	USD
CY2016Q2	kss	Shareswithheldfortaxesonvestedrestrictedshares Shareswithheldfortaxesonvestedrestrictedshares	12000000	USD
CY2017Q2	kss	Shareswithheldfortaxesonvestedrestrictedshares Shareswithheldfortaxesonvestedrestrictedshares	10000000	USD
CY2017Q2	kss	Stock Issued During Period Value Stock Option Exercised And Stock Based Compensation Expense StockIssuedDuringPeriodValueStockOptionExercisedAndStockBasedCompensationExpense	0	USD
CY2016Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	1346000000	USD
CY2017Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	1507000000	USD
CY2017Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	1480000000	USD
CY2016Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	48000000	USD
CY2017Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	112000000	USD
CY2017Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	137000000	USD
CY2016Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1126000000	USD
CY2017Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1224000000	USD
CY2017Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1088000000	USD
CY2016Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-16000000	USD
CY2017Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-14000000	USD
CY2017Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-13000000	USD
CY2016Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	2961000000	USD
CY2017Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	3003000000	USD
CY2017Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	3013000000	USD
CY2016Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4000000	shares
CY2017Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3000000	shares
CY2016Q2	us-gaap	Assets Assets	13304000000	USD
CY2017Q1	us-gaap	Assets Assets	13574000000	USD
CY2017Q2	us-gaap	Assets Assets	13244000000	USD
CY2016Q2	us-gaap	Assets Current AssetsCurrent	4855000000	USD
CY2017Q1	us-gaap	Assets Current AssetsCurrent	5247000000	USD
CY2017Q2	us-gaap	Assets Current AssetsCurrent	4944000000	USD
CY2016Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	707000000	USD
CY2016Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	423000000	USD
CY2017Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1074000000	USD
CY2017Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	625000000	USD
CY2016Q2	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-284000000	USD
CY2017Q2	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-449000000	USD
CY2017Q2	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.55
CY2016Q2	us-gaap	Common Stock Value CommonStockValue	4000000	USD
CY2017Q1	us-gaap	Common Stock Value CommonStockValue	4000000	USD
CY2017Q2	us-gaap	Common Stock Value CommonStockValue	4000000	USD
CY2017Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	67000000	USD
CY2016Q2	us-gaap	Cost Of Goods Sold CostOfGoodsSold	2560000000	USD
CY2017Q2	us-gaap	Cost Of Goods Sold CostOfGoodsSold	2445000000	USD
CY2016Q2	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	22000000	USD
CY2017Q2	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	20000000	USD
CY2016Q2	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-18000000	USD
CY2017Q2	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	13000000	USD
CY2016Q2	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	239000000	USD
CY2017Q1	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	272000000	USD
CY2017Q2	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	285000000	USD
CY2016Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	234000000	USD
CY2017Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	238000000	USD
CY2017Q2	us-gaap	Dividends Dividends	94000000	USD
CY2016Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.09
CY2017Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.39
CY2016Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.09
CY2017Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.39
CY2016Q2	us-gaap	Gross Profit GrossProfit	1412000000	USD
CY2017Q2	us-gaap	Gross Profit GrossProfit	1398000000	USD
CY2016Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	27000000	USD
CY2017Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	109000000	USD
CY2016Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	10000000	USD
CY2017Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	43000000	USD
CY2016Q2	us-gaap	Income Taxes Paid IncomeTaxesPaid	126000000	USD
CY2017Q2	us-gaap	Income Taxes Paid IncomeTaxesPaid	5000000	USD
CY2016Q2	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	95000000	USD
CY2017Q2	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-27000000	USD
CY2016Q2	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-87000000	USD
CY2017Q2	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	26000000	USD
CY2016Q2	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-125000000	USD
CY2017Q2	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-117000000	USD
CY2016Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	44000000	USD
CY2017Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	193000000	USD
CY2016Q2	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	15000000	USD
CY2017Q2	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-42000000	USD
CY2016Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-79000000	USD
CY2017Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-76000000	USD
CY2016Q2	us-gaap	Interest Paid Net InterestPaidNet	50000000	USD
CY2017Q2	us-gaap	Interest Paid Net InterestPaidNet	46000000	USD
CY2016Q2	us-gaap	Inventory Net InventoryNet	4084000000	USD
CY2017Q1	us-gaap	Inventory Net InventoryNet	3795000000	USD
CY2017Q2	us-gaap	Inventory Net InventoryNet	3991000000	USD
CY2016Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	13304000000	USD
CY2017Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	13574000000	USD
CY2017Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	13244000000	USD
CY2016Q2	us-gaap	Liabilities Current LiabilitiesCurrent	2647000000	USD
CY2017Q1	us-gaap	Liabilities Current LiabilitiesCurrent	2974000000	USD
CY2017Q2	us-gaap	Liabilities Current LiabilitiesCurrent	2839000000	USD
CY2016Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	558000000	USD
CY2017Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	671000000	USD
CY2017Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	674000000	USD
CY2016Q2	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	1770000000	USD
CY2017Q1	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	1685000000	USD
CY2017Q2	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	1657000000	USD
CY2016Q2	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	127000000	USD
CY2017Q1	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	131000000	USD
CY2017Q2	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	134000000	USD
CY2016Q2	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	2800000000	USD
CY2017Q1	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	2700000000	USD
CY2017Q2	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	2800000000	USD
CY2016Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	2793000000	USD
CY2017Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	2795000000	USD
CY2017Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	2795000000	USD
CY2016Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-250000000	USD
CY2017Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-292000000	USD
CY2016Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-174000000	USD
CY2017Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-203000000	USD
CY2016Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	140000000	USD
CY2017Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	46000000	USD
CY2016Q2	us-gaap	Net Income Loss NetIncomeLoss	17000000	USD
CY2017Q2	us-gaap	Net Income Loss NetIncomeLoss	66000000	USD
CY2016Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	106000000	USD
CY2017Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	185000000	USD
CY2016Q2	us-gaap	Other Assets Current OtherAssetsCurrent	348000000	USD
CY2017Q1	us-gaap	Other Assets Current OtherAssetsCurrent	378000000	USD
CY2017Q2	us-gaap	Other Assets Current OtherAssetsCurrent	328000000	USD
CY2016Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	219000000	USD
CY2017Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	224000000	USD
CY2017Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	231000000	USD
CY2016Q2	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-7000000	USD
CY2017Q2	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	12000000	USD
CY2016Q2	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-3000000	USD
CY2017Q2	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-13000000	USD
CY2016Q2	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	126000000	USD
CY2017Q2	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	156000000	USD
CY2017Q2	us-gaap	Payments For Restructuring PaymentsForRestructuring	4000000	USD
CY2016Q2	us-gaap	Payments Of Dividends PaymentsOfDividends	91000000	USD
CY2017Q2	us-gaap	Payments Of Dividends PaymentsOfDividends	94000000	USD
CY2016Q2	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	177000000	USD
CY2017Q2	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	216000000	USD
CY2016Q2	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	6000000	USD
CY2016Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	8230000000	USD
CY2017Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	8103000000	USD
CY2017Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	8069000000	USD
CY2016Q2	us-gaap	Repayments Of Long Term Debt And Capital Securities RepaymentsOfLongTermDebtAndCapitalSecurities	31000000	USD
CY2017Q2	us-gaap	Repayments Of Long Term Debt And Capital Securities RepaymentsOfLongTermDebtAndCapitalSecurities	32000000	USD
CY2017Q1	us-gaap	Restructuring Reserve RestructuringReserve	106000000	USD
CY2017Q2	us-gaap	Restructuring Reserve RestructuringReserve	102000000	USD
CY2016Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	12254000000	USD
CY2017Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	12522000000	USD
CY2017Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	12493000000	USD
CY2016Q2	us-gaap	Sales Revenue Net SalesRevenueNet	3972000000	USD
CY2017Q2	us-gaap	Sales Revenue Net SalesRevenueNet	3843000000	USD
CY2016Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1008000000	USD
CY2017Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	975000000	USD
CY2016Q2	us-gaap	Share Based Compensation ShareBasedCompensation	12000000	USD
CY2017Q2	us-gaap	Share Based Compensation ShareBasedCompensation	10000000	USD
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	68000	shares
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	1085000	shares
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	38.08
CY2016Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	2163000	shares
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	2665000	shares
CY2016Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	52.75
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	46.58
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	60.58
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	435000	shares
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1915000	shares
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	51.64
CY2017Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.00
CY2016Q1	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	2350000	shares
CY2017Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue	53.09
CY2016Q1	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	53.29
CY2017Q2	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2016Q2	us-gaap	Stockholders Equity StockholdersEquity	5297000000	USD
CY2017Q1	us-gaap	Stockholders Equity StockholdersEquity	5177000000	USD
CY2017Q2	us-gaap	Stockholders Equity StockholdersEquity	4994000000	USD
CY2016Q2	us-gaap	Treasury Stock Value TreasuryStockValue	9906000000	USD
CY2017Q1	us-gaap	Treasury Stock Value TreasuryStockValue	10338000000	USD
CY2017Q2	us-gaap	Treasury Stock Value TreasuryStockValue	10503000000	USD
CY2017Q2	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	156000000	USD
CY2016Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1000000	shares
CY2017Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1000000	shares
CY2016Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	184000000	shares
CY2017Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	171000000	shares
CY2016Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	183000000	shares
CY2017Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	170000000	shares

Files In Submission

Name	View Source	Status
0000885639-17-000015-index-headers.html	Edgar Link	pending
0000885639-17-000015-index.html	Edgar Link	pending
0000885639-17-000015.txt	Edgar Link	pending
0000885639-17-000015-xbrl.zip	Edgar Link	pending
ex321q117.htm	Edgar Link	pending
exhibit311q117.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
kohlslogoa04a01a01a01a07.jpg	Edgar Link	pending
kohls_10qxq1x2017.htm	Edgar Link	pending
kss-20170429.xml	Edgar Link	completed
kss-20170429.xsd	Edgar Link	pending
kss-20170429_cal.xml	Edgar Link	unprocessable
kss-20170429_def.xml	Edgar Link	unprocessable
kss-20170429_lab.xml	Edgar Link	unprocessable
kss-20170429_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$KSS
KOHLS Corp Stock $kss

2017 Q2 Form 10-Q Financial Statement

#000088563917000015 Filed on June 02, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KSS KOHLS Corp Stock $kss

2017 Q2 Form 10-Q Financial Statement

#000088563917000015 Filed on June 02, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KSS
KOHLS Corp Stock $kss